Of the seventeen variants (BCOR n = 5, BCORL1 n = 5, BCL6 n = 7), we identified three variants (18%) as possibly pathogenic (R1532fs, V1687fs, E1655fs) in the AML/MDS cohort (Figure 2). This evidence concerns the gene BCOR and myelodysplastic syndrome.